ALGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $143.74
Market Cap (MRQ) $10.24B
P/E (TTM) 25.0
EPS (TTM) $5.74
Revenue (TTM) $4.14B
ROE (TTM) 10.2%
52W Range $125–$200

ALGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Align Technology, Inc. - Common Stock Company overview from Wikipedia

05 · wikidata

Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.

Invisalign

Invisalign is a brand of clear aligners manufactured by Align Technology. The clear align system had been used to treat more than 18 million patients by 2017, and 22 million patients by 2026.

Align Technology founder Zia Chishti conceived of the basic design of Invisalign while an adult orthodontics patient. During his treatment with a retainer intended to complete his treatment, he posited that a series of such devices could effect a large final placement in a series of small movements. He partnered with Kelsey Wirth to seek developers.

Invisalign was approved by the Food and Drug Administration in 1998, and sales began in the U.S. in 1999. Orthodontists were resistant to adopting Invisalign at first, in particular because the founders had no orthodontic credentials or expertise, but the product became popular among consumers. The company raised about $140 million in funding over four rounds from 1997 to 2000. In 2000 Align Technology planned a $31 million television advertising campaign that The New York Times said would be "the most aggressive consumer advertising plan the dental profession has ever seen". In 2001, $130 million in additional funding was raised through an initial public offering on NASDAQ. By 2001, 75 percent of the 8,500 orthodontists in North America had been trained on the Invisalign system. That same year, Align Technology made Invisalign available to general dentists following a class-action lawsuit that alleged making the system available only to orthodontists resulted in unfair competition for dentists.

In the early 2000s, Align Technology was spending nearly all of its revenues on marketing and advertising, and losing about $18 million per year. Cofounders Wirth and Chishti resigned from Align Technology in 2001 and 2003 respectively, with Thomas Prescott replacing Chishti as CEO in March 2002. Prescott re-focused the company on North America and cut the marketing budget to about one-third its original size.

The Invisalign system grew from 80,000 patients in 2002 to 175,000 in 2004. It won several awards for stereolithography, medical design and fast growth. Align Technology was profitable for the first time in 2003. In 2005 the company expanded into Japan, and acquired General Orthodontic, an orthodontics firm that supported doctors prescribing the Invisalign system. Later that year, the Harvard School of Dental Medicine began requiring that its orthodontic graduate students complete Invisalign certification before they graduate.

The Invisalign Express 10, which uses 10 aligners, was introduced in 2005. Invisalign 1.5 was released in 2009. It was followed by Invisalign G3 in 2010 and G4 in 2011. Invisalign G3 and G4 were designed for more complex treatments. An Invisalign Express 5 version, which uses 5 aligners, was introduced in 2012. In February 2014, Align Technology released a G5 product designed to treat deep bites.

Support, software engineering, pre-production and administrative functions are done from Align Technology's headquarters in California. The manufacturing of Invisalign aligners is performed in Mexico, and treatment plans are created in Costa Rica. Align Technology also operates separate subsidiaries in Hong Kong and Australia that sell Invisalign in their respective markets. Align Technology provides training and certification to doctors.

In 2007 the Academy of General Dentistry approved Align Technology's Program Approval for Continuing Education (PACE) program. The company also created the AlignTech Institute, which provides educational resources to doctors. In March 2011 Align Technology acquired Cadent System, Inc., a dentist firm, for $190 million.

A major revision to the manufacturing process was started in 2026, a switch from mold-based appliance manufacture to 3D-printing, aimed at reducing the cost and complexity of the manufacturing process through disintermediation.

History

Align Technology was founded in 1997 by Zia Chishti and Kelsey Wirth, classmates at Stanford Graduate School of Business, and began working on the development of a clear aligner. Align received FDA clearance to market the Invisalign system in 1998, and it was first marketed in 2000. Align Technology went public on January 26, 2001, on the Nasdaq Stock Market.

In March 2011 Align acquired the Israeli company Cadent for $190 million; Cadent manufactured intraoral scanners that included 3D imaging, as well as software to display the acquired images and to plan treatment.

Joseph M. Hogan joined Align in June 2015, and is CEO and president.

The company's sales reached $1 billion for the first time in 2016 and its products were being used in about 8% of people who got braces. In 2017 the company was faced with the challenge of the expiration of its patents on its Invisalign system starting in October 2017 and the beginning of generic competition.

In March 2020, Align Technology announced that it has signed a definitive agreement to acquire exocad Global Holdings for approximately $418.7 million.

As of February 2023, Align Technology has assisted over 234,000 doctors and over 14.5 million patients worldwide.

In September 2023, it was announced Align Technology had acquired the Vienna-headquartered 3D printing technology and materials company, Cubicure GmbH.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorHealth Care industryHealth Care employees20,435 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$4.03B
2016-12-31 → 2025-12-31
EPS$5.65
2016-12-31 → 2025-12-31
Free Cash Flow$491M
2016-12-31 → 2025-12-31
Net margin10.0%
2016-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend ALGN 5Y avg Peer Median Verdict
P/E (TTM) 25.05Y avg ≈45.1 ≈45.1 28.5 Overvalued
P/S (TTM) 2.55Y avg ≈5.9 ≈5.9 2.1 Overvalued
P/B (MRQ) 2.45Y avg ≈6.2 ≈6.2 2.1 Overvalued
Price / FCF (TTM) 16.25Y avg ≈41.4 ≈41.4 · ·
Price / Cash Flow (TTM) 13.65Y avg ≈27.7 ≈27.7 17.6 Overvalued
Price / Tangible Book (MRQ) 2.55Y avg ≈7.3 ≈7.3 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 4.2%
Next Report Oct 28, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Jul 29, 2026 $2.64 $2.66 -0.87%
March 31, 2026 $2.58 $2.33 11.0%
Dec. 31, 2025 $3.29 $3.03 8.5%
Sept. 30, 2025 $2.61 $2.45 6.5%
June 30, 2025 $2.49 $2.62 -5.0%
March 31, 2025 $2.13 $2.02 5.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 17
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $4.03B$4.00B$3.86B$3.73B$3.95B$2.47B$2.41B$1.97B$1.47B$1.08B$845M$762M
Cost of Revenue $1.32B$1.20B$1.16B$1.10B$1.02B$709M$663M$519M$356M$265M$205M$183M
Gross Profit $2.71B$2.80B$2.71B$2.63B$2.94B$1.76B$1.74B$1.45B$1.12B$815M$640M$578M
R&D Expense $370M$364M$347M$305M$250M$175M$157M$129M$98M$76M$61M$53M
SG&A Expense $1.76B$1.76B$1.70B$1.67B$1.71B$1.20B$1.07B$852M··$390M$332M
Operating Expenses $2.17B$2.19B$2.06B$1.99B$1.96B$1.38B$1.20B$981M$763M$566M$451M$385M
Operating Income $546M$608M$643M$643M$976M$387M$542M$467M$354M$249M$189M$194M
Interest Income ······$12M$9M$7M$4M··
Other Non-op $23M$-19M$-19M$-49M$33M$-11M$8M$-8M$4M$-11M$-3M$-3M
Pretax Income $585M$609M$641M$599M$1.01B$379M$563M$467M$365M$243M$186M$190M
Income Tax $175M$188M$196M$237M$240M$-1.40B$112M$58M$130M$51M$42M$45M
Net Income $410M$421M$445M$362M$772M$1.78B$443M$400M$231M$190M$144M$146M
EPS (Basic) $5.66$5.63$5.82$4.62$9.78$22.55$5.57$5.00$2.89$2.38$1.80$1.81
EPS (Diluted) $5.65$5.62$5.81$4.61$9.69$22.41$5.53$4.92$2.83$2.33$1.77$1.77
Shares (Basic) 72,542,00074,877,00076,426,00078,190,00078,917,00078,760,00079,424,00080,064,00080,085,00079,856,00079,998,00080,754,000
Shares (Diluted) 72,588,00074,993,00076,568,00078,420,00079,670,00079,230,00080,100,00081,357,00081,832,00081,484,00081,521,00082,283,000
EBITDA $783M$753M$786M$768M$1.09B$481M$621M$521M$391M$273M$207M$211M
Balance Sheet 27
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $1.09B$1.04B$937M$942M$1.10B$961M$550M$637M$450M$389M$168M$200M
Short-term Investments ······$318M$98M$272M$251M$360M$255M
Receivables $1.10B$996M$903M$860M$897M$658M$550M$439M$324M$247M$159M$130M
Inventory $226M$254M$297M$339M$230M$139M$112M$56M$32M$27M$19M$16M
Prepaid Expense $166M$199M$274M$226M$195M$92M$102M$72M$81M$38M$27M$20M
Other Current Assets $47M$82M$77M$17M$31M$62M$24M$7M····
Current Assets $2.62B$2.49B$2.45B$2.42B$2.49B$1.85B$1.63B$1.30B$1.16B$953M$732M$657M
PP&E (Net) $1.13B$1.27B$1.29B$1.23B$1.08B$735M$632M$521M$349M$175M$136M$90M
PP&E (Gross) $1.90B$1.93B$1.84B$1.68B$1.44B$1.04B$861M$693M$485M$311M$255M$198M
Accum. Depreciation $767M$662M$551M$450M$359M$301M$230M$172M$136M$136M$118M$108M
Goodwill $492M$443M$420M$408M$419M$445M$64M$64M$65M$61M$61M$61M
Intangibles $94M$103M$82M$96M$110M$130M$12M$18M$24M$21M$18M$21M
Other Non-current Assets $278M$234M$129M$56M$58M$35M$40M$27M$44M$13M$8M$8M
Total Assets $6.23B$6.21B$6.08B$5.95B$5.94B$4.83B$2.50B$2.05B$1.78B$1.40B$1.16B$988M
Accounts Payable $121M$109M$113M$128M$164M$142M$87M$64M$37M$29M$34M$23M
Accrued Liabilities $537M$598M$526M$454M$607M$406M$320M$235M$196M$134M$108M$88M
Current Liabilities $1.92B$2.04B$2.07B$1.93B$1.92B$1.33B$971M$692M$500M$354M$272M$202M
Capital Leases $83M$88M$97M$100M$103M$64M$43M$0····
Other Non-current Liabilities $114M$140M$173M$196M$175M$100M$37M$29M$16M$1M$2M$3M
Total Liabilities $2.18B$2.36B$2.45B$2.35B$2.32B$1.60B$1.15B$800M$630M$401M$311M$235M
Common Stock $7.0K$7.0K$7.0K$8.0K$8.0K$8.0K$8.0K$8.0K$8.0K$8.0K$8.0K$8.0K
Paid-in Capital $1.51B$1.36B$1.16B$1.04B$999M$975M$907M$878M$886M$865M$822M$783M
Retained Earnings $2.46B$2.48B$2.45B$2.57B$2.62B$2.22B$440M$378M$267M$131M$27M$-31M
AOCI $75M$6M$21M$-10M$4M$44M$-688.0K$-3M$571.0K$-938.0K$-980.0K$-140.0K
Stockholders' Equity $4.05B$3.85B$3.63B$3.60B$3.62B$3.23B$1.35B$1.25B$1.15B$999M$848M$753M
Liabilities + Equity $6.23B$6.21B$6.08B$5.95B$5.94B$4.83B$2.50B$2.05B$1.78B$1.40B$1.16B$988M
Shares Outstanding 71,364,00073,849,00075,075,00077,267,00078,710,00078,860,00078,433,00079,778,00080,040,00079,553,00079,500,00080,205,000
Cash Flow 16
Metric Trend 202520242023202220212020201920182017201620152014
D&A $237M$145M$142M$126M$109M$94M$79M$55M$38M$24M$18M$18M
Stock-based Comp $186M$174M$154M$133M$114M$98M$88M$71M$59M$54M$53M$40M
Deferred Tax $33M$26M$-19M$-39M$15M$-1.49B$307.0K$-16M$18M$-16M$-11M$4M
Amort. of Intangibles $19M$19M$16M$16M$17M$13M$6M$6M$6M$3M··
Restructuring ·$37M$14M$10M········
Other Non-cash $-274M$-28M$63M$-13M$162M$186M$137M$45M$93M$-4M$34M$-2M
Operating Cash Flow $593M$738M$786M$569M$1.17B$662M$747M$555M$439M$248M$238M$227M
CapEx $102M$116M$178M$292M$401M$155M$150M$223M$196M$71M$53M$24M
Investing Cash Flow $-112M$-255M$-196M$-213M$-563M$-232M$-350M$7M$-251M$73M$-166M$-202M
Stock Issued $22M$25M$27M$26M$26M$20M$18M$17M$14M$14M$11M$18M
Stock Repurchased $466M$353M$592M$435M$375M$0$400M$300M$104M$96M$102M$98M
Net Stock Activity $-444M$-328M$-566M$-409M$-349M$20M$-382M$-283M$-89M$-82M$-90M$-80M
Financing Cash Flow $-465M$-356M$-598M$-502M$-458M$-31M$-486M$-369M$-136M$-96M$-101M$-66M
Net Change in Cash $51M$106M$-4M$-158M$139M$410M$-86M$187M$57M$222M$-32M$-43M
Taxes Paid $135M···········
Free Cash Flow $491M$623M$608M$277M$771M$507M$598M$331M$243M$177M$185M$203M
Profitability 8
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 67.2%70.0%70.1%70.5%74.3%71.3%72.5%73.6%75.8%75.5%75.7%75.9%
Operating Margin 13.5%15.2%16.7%17.2%24.7%15.7%22.5%23.7%24.0%23.1%22.3%25.4%
Net Margin 10.2%10.5%11.5%9.7%19.5%71.8%18.4%20.3%15.7%17.6%17.0%19.1%
Pretax Margin 14.5%15.2%16.6%16.0%25.6%15.3%23.4%23.7%24.8%22.5%22.0%25.0%
EBITDA Margin 19.4%18.8%20.3%20.6%27.5%19.4%25.8%26.5%26.6%25.3%24.4%27.8%
ROA 6.6%6.9%7.4%6.1%14.3%48.4%19.4%20.9%14.6%14.8%13.4%16.0%
ROE 10.3%10.8%12.0%9.9%21.6%56.7%33.4%32.7%21.5%20.6%18.0%21.0%
ROIC 9.4%10.9%12.3%10.8%20.5%56.1%32.2%32.6%19.8%19.7%17.2%19.7%
Liquidity & Solvency 2
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 1.41.21.21.31.31.41.71.92.32.72.73.3
Quick Ratio 1.11.00.90.91.01.21.51.72.12.52.52.9
Efficiency 3
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 0.60.70.60.60.70.71.11.00.90.80.80.8
Inventory Turnover 5.54.43.63.95.55.67.911.912.111.411.612.3
Receivables Turnover 3.84.24.44.35.14.14.95.25.25.35.96.3
Per Share 5
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $56.74$52.16$48.36$46.61$46.03$41.01$17.16$15.70$14.37$12.51$10.67$9.39
Revenue / Share $55.59$53.33$50.44$47.62$49.61$31.20$30.05$24.17$18.01$13.25$10.37$9.26
Cash Flow / Share $8.17$9.84$10.26$7.25$14.72$8.36$9.33$6.82$5.36$3.04$2.92$2.76
Cash / Share $15.34$14.14$12.49$12.19$13.97$12.18$7.02$7.98$5.62$4.89$2.11$2.49
EPS (TTM) $5.65$5.62$5.81$4.61$9.69$22.41$5.53$4.92$2.83$2.33$1.77$1.77
Growth Rates 9
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 0.90%3.5%3.4%-5.5%59.9%·······
Revenue CAGR 3Y 2.6%0.39%16.0%·········
Revenue CAGR 5Y 10.3%···········
EPS YoY 0.53%-3.3%26.0%-52.4%-56.8%·······
EPS CAGR 3Y 7.0%-16.6%-36.2%·········
EPS CAGR 5Y -24.1%···········
Net Income YoY -2.6%-5.3%23.1%-53.2%-56.5%·······
Net Income CAGR 3Y 4.3%-18.3%-37.0%·········
Net Income CAGR 5Y -25.4%···········
Valuation (TTM) 10
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $4.03B$4.00B$3.86B$3.73B$3.95B$2.47B$2.41B$1.97B$1.47B$1.08B$845M$762M
Net Income TTM $410M$421M$445M$362M$772M$1.78B$443M$400M$231M$190M$144M$146M
Market Cap $11.14B$15.40B$20.57B$16.30B$51.73B$42.14B$21.89B$16.71B$17.78B$7.65B$5.24B$4.48B
P/E 27.637.147.245.767.823.850.542.678.541.337.231.6
P/S 2.83.95.34.413.117.09.18.512.17.16.25.9
P/B 2.84.05.74.514.313.016.313.315.57.76.26.0
P / Tangible Book 3.24.76.65.316.715.8······
P / Cash Flow 18.820.926.228.744.163.629.330.140.630.922.019.8
P / FCF 22.724.733.858.967.183.136.650.473.243.228.422.1
Earnings Yield 3.6%2.7%2.1%2.2%1.5%4.2%2.0%2.4%1.3%2.4%2.7%3.2%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $4.03B $4.00B $3.86B $3.73B $3.95B
Gross Margin % 67.2% 70.0% 70.1% 70.5% 74.3%
Operating Margin % 13.5% 15.2% 16.7% 17.2% 24.7%
Net Income $410M $421M $445M $362M $772M
Diluted EPS $5.65 $5.62 $5.81 $4.61 $9.69

Institutional owners (13F) 750 filers · $13.7B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 750
Value held $13.7B
New positions 72
Exited positions 81
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
72 (-73 vs prior Q) 81 (-2 vs prior Q) 215 (-34 vs prior Q) 289 (+61 vs prior Q) +3.4M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $1,277,272,490 8,179,779 9.31% Shares
BlackRock, Inc. $745,370,304 4,419,366 5.44% Shares
VANGUARD CAPITAL MANAGEMENT LLC $742,325,451 4,401,313 5.41% Shares
FMR LLC $684,765,036 4,060,032 4.99% Shares
Capital International Investors $682,324,318 4,045,561 4.98% Shares
Capital World Investors $577,219,454 3,422,385 4.21% Shares
GOLDMAN SACHS GROUP INC $568,849,702 3,372,760 4.15% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $528,203,316 3,131,764 3.85% Shares
STATE STREET CORP $431,518,634 2,558,512 3.15% Shares
GEODE CAPITAL MANAGEMENT, LLC $378,153,032 2,245,315 2.76% Shares
Ninety One UK Ltd $372,703,280 2,209,791 2.72% Shares
UBS Group AG $358,450,738 2,125,286 2.61% Shares
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $292,369,455 1,733,484 2.13% Shares
DIMENSIONAL FUND ADVISORS LP $242,715,391 1,438,900 1.77% Shares
Invesco Ltd. $238,412,210 1,413,567 1.74% Shares
Ruane, Cunniff & Goldfarb L.P. $197,577,600 1,171,455 1.44% Shares
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $180,736,225 1,071,601 1.32% Shares
JACOBS LEVY EQUITY MANAGEMENT, INC $180,291,468 1,068,964 1.31% Shares
MORGAN STANLEY $170,994,867 1,013,842 1.25% Shares
NORGES BANK $152,573,715 904,623 1.11% Shares
AQR CAPITAL MANAGEMENT LLC $151,163,848 899,731 1.10% Shares
JPMORGAN CHASE & CO $134,654,324 773,182 0.98% Shares
DISCIPLINED GROWTH INVESTORS INC /MN $132,090,801 783,178 0.96% Shares
Senvest Management, LLC $125,709,888 745,345 0.92% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $112,686,638 668,129 0.82% Shares
Swedbank AB $111,012,012 658,200 0.81% Shares
BARCLAYS PLC $108,101,615 640,944 0.79% Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $107,285,353 625,826 0.78% Shares
Assenagon Asset Management S.A. $106,450,265 631,153 0.78% Shares
VOYA INVESTMENT MANAGEMENT LLC $105,404,604 624,952 0.77% Shares
DEUTSCHE BANK AG\ $99,778,582 591,596 0.73% Shares
NORTHERN TRUST CORP $94,827,567 562,241 0.69% Shares
BANK OF AMERICA CORP /DE/ $93,085,478 551,912 0.68% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $79,759,314 472,900 0.58% Put option
FEDERATED HERMES, INC. $78,222,317 463,787 0.57% Shares
Bares Capital Management, Inc. $76,349,389 609,722 0.56% Shares
Amundi $73,309,080 434,656 0.53% Shares
BROWN ADVISORY INC $69,759,715 413,611 0.51% Shares
DAVENPORT & Co LLC $64,891,092 384,745 0.47% Shares
VANGUARD FIDUCIARY TRUST CO $63,304,170 375,336 0.46% Shares
JENNISON ASSOCIATES LLC $59,641,380 353,619 0.43% Shares
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $59,357,000 351,934 0.43% Shares
Bank of New York Mellon Corp $57,062,230 338,327 0.42% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $56,163,780 333,000 0.41% Call option
Carmignac Gestion $53,495,676 316,832 0.39% Shares
CITADEL ADVISORS LLC $50,443,170 299,082 0.37% Shares
Resona Asset Management Co.,Ltd. $49,583,874 291,177 0.36% Shares
KEYBANK NATIONAL ASSOCIATION/OH $47,572,414 282,061 0.35% Shares
WELLS FARGO & COMPANY/MN $47,249,188 280,145 0.34% Shares
Nearwater Capital Markets, Ltd $45,200,880 268,000 0.33% Shares

Show all 750 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Danaher Corporation ×3 filings Nov. 14, 2013 · Initial filing Passive investment SEC
1. Danaher Corporation Feb. 22, 2011 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 66 insiders · 24 officers · 17 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Joseph M Hogan President and CEO Feb. 20, 2026 M 209,270 0 0 $0
John Morici EVP, CHIEF FINANCIAL OFFICER Feb. 20, 2026 M 13,536 0 1 $-1,508,611
Kenneth Arola VP, Finance and CFO Feb. 20, 2013 C 31,682 0 0 $0
Julie Ann Coletti EVP, CHIEF LEGAL & REGULATORY Feb. 20, 2026 M 11,445 0 0 $0
Stuart A Hockridge EVP, GLOBAL HR Feb. 20, 2026 M 14,892 0 0 $0
Emory Wright EVP, GLOBAL OPERATIONS Feb. 20, 2024 A 8,294 0 0 $0
Jennifer Olson SVP & Mng Dir Cust Service Nov. 6, 2020 G 2,277 0 0 $0
Yuval Shaked SVP & Mng Dir. Itero Nov. 4, 2020 S 636 0 0 $0
Zelko Relic SVp, R&D and CTO Nov. 4, 2020 S 13,716 0 0 $0
Markus Christof Sebstian SVP & Mng Dir EMEA Oct. 20, 2020 M 613 0 0 $0
Simon Beard SVP and Mgng Director, EMEA Aug. 27, 2020 S 17,670 0 0 $0
Vamsi Mohan Raj Pudipeddi SVP, Chief Marketing Officer May 18, 2020 S 0 0 0 $0
Sreelakshmi Kolli SVP & Mng Dir Info Tech Feb. 20, 2020 M 13,409 0 0 $0
Raphael Pascaud CMO & Bus. Dev. Oct. 1, 2019 M 27,156 0 0 $0
Julie Tay SVP & Mng Dir. Asia Pacific May 8, 2019 S 17,746 0 0 $0
Christopher C. Puco VP, No. American Sales Nov. 30, 2018 S 0 0 0 $0
Lynn Pendergrass VP, Americas March 20, 2017 A · 0 0 $0
Timothy A Mack VP, Bus Dev Feb. 20, 2016 M 0 0 0 $0
Jennifer Erfurth VP, Global HR Feb. 20, 2016 A 10,760 0 0 $0
John Patrick Graham VP, Mktg & CMO May 5, 2015 S 0 0 0 $0
Richard M.L. Twomey VP International Oct. 30, 2013 M 4,272 0 0 $0
Dana Cambra VP, R&D June 18, 2012 C 4,398 0 0 $0
Sheila K Tan VP Marketing & CMO Nov. 17, 2011 C 19,523 0 0 $0
Afsaneh Azadeh Chief Information Officer Feb. 20, 2008 A · 0 0 $0
Quentin S. Blackford Director Aug. 27, 2026 A · 0 0 $0
Anne Myong Director May 20, 2026 A 9,830 0 0 $0
Mojdeh Poul Director May 20, 2026 A 3,553 0 0 $0
Kevin J Dallas Director May 20, 2026 A 16,168 0 0 $0
Britt J. Vitalone Director May 20, 2026 A 1,443 0 0 $0
Andrea Lynn Saia Director May 20, 2026 A 17,318 0 0 $0
Kevin T Conroy Director May 20, 2026 A 3,553 0 0 $0
Susan E Siegel Director May 20, 2026 A 10,723 0 0 $0
Joseph Lacob Director May 20, 2026 A 135,916 0 0 $0
MORROW GEORGE J Director May 20, 2026 M 5,036 0 0 $0
Raymond C Larkin JR Director May 20, 2026 A 27,454 0 0 $0
Warren S Thaler Director May 17, 2023 M 31,780 0 0 $0
Greg J Santora Director May 17, 2023 M 11,987 0 0 $0
Thomas M Prescott Director May 19, 2021 M 54,129 0 0 $0
David E Collins Director May 15, 2014 C 25,900 0 0 $0
Brian H Dovey Director May 19, 2004 A 0 0 0 $0
DANAHER CORP /DE/ 10% owner Nov. 13, 2013 S 3,837,132 0 0 $0
KLEINER PERKINS CAUFIELD & BYERS VIII LP 10% owner Nov. 10, 2004 J 1,492,421 0 0 $0
Roger E George · May 14, 2019 S 11,773 0 0 $0
David L White · Nov. 18, 2016 G 5,913 0 0 $0
David C Nagel · May 13, 2016 M 30,200 0 0 $0
Len Hedge · Feb. 20, 2013 C 55,861 0 0 $0
Dan Scott Ellis · Nov. 19, 2012 M 3,552 0 0 $0
Gil Laks · Feb. 24, 2010 C 9,773 0 0 $0
Sonia Clark · Sept. 25, 2008 C 1,806 0 0 $0
Darrell Zoromski · Aug. 20, 2008 C 1,647 0 0 $0
Kent H Bowen · May 15, 2008 C 84,500 0 0 $0
Hossein Arjomand · Nov. 26, 2007 C 617 0 0 $0
Eldon M Bullington · Nov. 26, 2007 C 4,967 0 0 $0
Michael J Henry · May 1, 2007 S 0 0 0 $0
Kelsey Wirth · May 2, 2006 S 1,074,022 0 0 $0
David Thrower · Aug. 10, 2005 M 15,980 0 0 $0
Brian Dovey · May 25, 2005 A · 0 0 $0
Rok Sribar · March 1, 2005 A · 0 0 $0
Robert D Mitchell · Feb. 22, 2005 A · 0 0 $0
Patricia L Wadors · Feb. 22, 2005 A · 0 0 $0
Cecilia Claudio · Feb. 22, 2005 A · 0 0 $0
KPCB VIII ASSOCIATES LP · Nov. 10, 2004 J 86,526 0 0 $0
Amir Abolfathi · Nov. 8, 2004 M 10,334 0 0 $0
Jon Fjeld · May 28, 2004 S 108,864 0 0 $0
Gordon Gund · May 10, 2004 P 68,659 0 0 $0
Joe Breeland · March 12, 2004 A 53,985 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 84 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
KMID · Virtus ETF Trust II 3.44% 9,273 NS July 31, 2026 N-PORT
PRNT · ARK ETF Trust 1.58% 5,467 NS July 31, 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1.55% 93,283 SH Oct. 1, 2026 Daily
RNIN · EA Series Trust 1.09% 11,732 NS July 31, 2026 N-PORT
ALTL · Pacer Funds Trust 0.90% 4,911 NS July 31, 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 0.85% 52,527 NS July 31, 2026 N-PORT
JDOC · J.P. Morgan Exchange-Traded Fund Tr… 0.70% 376 NS July 31, 2026 N-PORT
SPHB · Invesco Exchange-Traded Fund Trust … 0.63% 41,430 SH Oct. 1, 2026 Daily
HIBL · Direxion Shares ETF Trust 0.61% 2,712 NS July 31, 2026 N-PORT
PALC · Pacer Funds Trust 0.52% 6,492 NS July 31, 2026 N-PORT
QQQS · Invesco Exchange-Traded Fund Trust … 0.47% 751 SH Oct. 1, 2026 Daily
BKMC · BNY Mellon ETF Trust 0.28% 10,766 NS July 31, 2026 N-PORT
DFAT · Dimensional ETF Trust 0.28% 235,486 NS July 31, 2026 N-PORT
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0.25% 30,473 NS July 31, 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0.24% 990,688 SH Aug. 19, 2026 Daily
RSP · Invesco Exchange-Traded Fund Trust 0.20% 1,279,170 SH Oct. 1, 2026 Daily
VHT · VANGUARD WORLD FUND 0.17% 204,512 SH Aug. 19, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.17% 32,382 NS July 31, 2026 N-PORT
IYH · iShares Trust 0.16% 39,100 SH Sept. 11, 2026 Daily
ISCG · iShares Trust 0.15% 9,672 SH Sept. 11, 2026 Daily
FNX · First Trust Exchange-Traded AlphaDE… 0.15% 12,214 NS July 31, 2026 N-PORT
DFAS · Dimensional ETF Trust 0.15% 133,009 NS July 31, 2026 N-PORT
REVS · Columbia ETF Trust I 0.15% 2,860 NS July 31, 2026 N-PORT
FNK · First Trust Exchange-Traded AlphaDE… 0.14% 1,921 NS July 31, 2026 N-PORT
VB · VANGUARD INDEX FUNDS 0.14% 1,560,504 SH Aug. 19, 2026 Daily
VFQY · VANGUARD WELLINGTON FUND 0.14% 4,009 SH Aug. 19, 2026 Daily
ESML · iShares Trust 0.14% 25,829 SH Sept. 11, 2026 Daily
CURE · Direxion Shares ETF Trust 0.13% 1,311 NS July 31, 2026 N-PORT
IXJ · iShares Trust 0.13% 34,914 SH Sept. 11, 2026 Daily
IWS · iShares Trust 0.10% 100,293 SH Sept. 11, 2026 Daily
PEXL · Pacer Funds Trust 0.10% 295 NS July 31, 2026 N-PORT
WSML · iShares Trust 0.10% 4,205 SH Sept. 11, 2026 Daily
RECS · Columbia ETF Trust I 0.09% 32,471 NS July 31, 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0.09% 5,007 SH Oct. 1, 2026 Daily
VFVA · VANGUARD WELLINGTON FUND 0.09% 4,336 SH Aug. 19, 2026 Daily
VFMF · VANGUARD WELLINGTON FUND 0.08% 3,482 SH Aug. 19, 2026 Daily
IWR · iShares Trust 0.07% 274,791 SH Sept. 11, 2026 Daily
XOEF · iShares Trust 0.06% 83 SH Sept. 11, 2026 Daily
FAB · First Trust Exchange-Traded AlphaDE… 0.04% 424 NS July 31, 2026 N-PORT
VOOV · VANGUARD ADMIRAL FUNDS 0.04% 15,374 SH Aug. 19, 2026 Daily
DXUV · Dimensional ETF Trust 0.04% 1,211 NS July 31, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.04% 4,965 NS July 31, 2026 N-PORT
HDUS · Lattice Strategies Trust 0.03% 417 NS July 31, 2026 N-PORT
DFAC · Dimensional ETF Trust 0.03% 96,570 NS July 31, 2026 N-PORT
IVE · iShares Trust 0.03% 111,147 SH Sept. 11, 2026 Daily
IUSV · iShares Trust 0.03% 57,946 SH Sept. 11, 2026 Daily
DFUV · Dimensional ETF Trust 0.03% 27,760 NS July 31, 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0.03% 20,398 SH Oct. 1, 2026 Daily
VONV · VANGUARD SCOTTSDALE FUNDS 0.03% 40,343 SH Aug. 19, 2026 Daily
DCOR · Dimensional ETF Trust 0.03% 5,902 NS July 31, 2026 N-PORT
DSI · iShares Trust 0.03% 10,314 SH Sept. 11, 2026 Daily
IWD · iShares Trust 0.03% 148,444 SH Sept. 11, 2026 Daily
IUS · Invesco Exchange-Traded Self-Indexe… 0.03% 1,790 SH Oct. 1, 2026 Daily
TILT · FlexShares Trust 0.03% 3,318 NS July 31, 2026 N-PORT
OMFL · Invesco Exchange-Traded Self-Indexe… 0.02% 7,120 SH Oct. 1, 2026 Daily
DFAU · Dimensional ETF Trust 0.02% 15,866 NS July 31, 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0.02% 13,488 SH Oct. 1, 2026 Daily
VOO · VANGUARD INDEX FUNDS 0.02% 1,729,431 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.02% 2,161,771 SH Aug. 19, 2026 Daily
VONE · VANGUARD SCOTTSDALE FUNDS 0.02% 10,952 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.02% 5,657 SH Aug. 19, 2026 Daily
ESGV · VANGUARD WORLD FUND 0.02% 15,119 SH Aug. 19, 2026 Daily
TOPC · iShares Trust 0.02% 40 SH Sept. 11, 2026 Daily
QVML · Invesco Exchange-Traded Fund Trust … 0.02% 2,046 SH Oct. 1, 2026 Daily
DFUS · Dimensional ETF Trust 0.02% 21,777 NS July 31, 2026 N-PORT
PTLC · Pacer Funds Trust 0.02% 3,372 NS July 31, 2026 N-PORT
XVV · iShares Trust 0.02% 762 SH Sept. 11, 2026 Daily
SPUU · Direxion Shares ETF Trust 0.02% 251 NS July 31, 2026 N-PORT
QDPL · Pacer Funds Trust 0.02% 1,595 NS July 31, 2026 N-PORT
IVV · iShares Trust 0.02% 839,331 SH Sept. 11, 2026 Daily
PBP · Invesco Exchange-Traded Fund Trust 0.01% 393 SH Oct. 1, 2026 Daily
IWB · iShares Trust 0.01% 46,084 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.01% 18,798 SH Sept. 11, 2026 Daily
IYY · iShares Trust 0.01% 2,819 SH Sept. 11, 2026 Daily
HCMT · Direxion Shares ETF Trust 0.01% 464 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.01% 87,429 SH Sept. 11, 2026 Daily
SPXL · Direxion Shares ETF Trust 0.01% 5,207 NS July 31, 2026 N-PORT
PHDG · Invesco Actively Managed Exchange-T… 0.01% 53 SH Oct. 1, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.01% 58,076 SH Aug. 19, 2026 Daily
LGDX · Tidal Trust III 0.01% 71 NS July 31, 2026 N-PORT
FTLS · First Trust Exchange-Traded Fund III -0.16% -24,215 NS July 31, 2026 N-PORT
SLTY · Tidal Trust II -2.76% -3,000 NS July 31, 2026 N-PORT
ISCB · iShares Trust · 3,130 SH Sept. 11, 2026 Daily
ISCV · iShares Trust · 8,638 SH Sept. 11, 2026 Daily

ALGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 25 analysts BUY
Median target $207.00 +44.0%
7 28.0% Strong Buy
9 36.0% Buy
8 32.0% Hold
1 4.0% Sell
0 0.0% Strong Sell

12-Month Price Target

14 analysts · 2026-10-02

Mean target $206.36 +43.6%

← Below all targets Current price $143.74
Low$170.00 Mean$206.36 High$235.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ALGN $11.14B 27.6 0.90% 10.2% 10.3% 67.2%
MDLN · -4200.0 11.5% 4.1% 21.6% 26.4%
SOLV $13.75B 8.9 0.86% 18.7% 35.8% 53.5%
COO $13.70B 37.4 5.1% 9.2% 4.6% 65.5%
LNTH $4.30B 19.5 0.50% 15.2% 20.7% 61.1%
MMED $3.71B -10.2 14.2% -10.7% -9.3% 54.2%
MMSI $5.24B 41.4 11.8% 8.5% 8.4% 48.7%
HAE $2.45B 26.4 -2.0% 7.3% 11.8% 59.0%
QDEL $1.99B -1.8 -1.9% -41.4% -48.0% ·
ICUI $3.52B 4755.7 -6.3% 0.03% 0.03% 36.8%

Latest News Recent headlines mentioning this company

23

Trading Signals Recent buy/sell signals with entry price and risk/reward ratio

25

No open signal right now — no card is filled, and that's honest.

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 5, 2026